Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Pregabalin

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    (R-)-3-isobutyl GABA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 89Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fourrts’ Generics Pregabalin Receives Approval in US
    Fourrts’ Generics Pregabalin Receives Approval in US

    24 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218529

    FDA
    24 Feb 2026
    Share Share
    Health Ministry Proposes Pregabalin For Schedule H1 Inclusion
    Health Ministry Proposes Pregabalin For Schedule H1 Inclusion

    31 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183878&sid=1

    PHARMABIZ
    31 Jan 2026
    Share Share
    Drug Misuse: Govt May Curb 'Pregabalin' Sales
    Drug Misuse: Govt May Curb 'Pregabalin' Sales

    29 Jan 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-misuse-govt-may-curb-pregabalin-sales/articleshow/127730254.cms

    ECONOMICTIMES
    29 Jan 2026
    Share Share
    Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa
    Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa

    22 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183693&sid=1

    PHARMABIZ
    22 Jan 2026
    Share Share
    Pregabalin API Export Opportunities: Why Global Demand Is Rising
    Pregabalin API Export Opportunities: Why Global Demand Is Rising

    04 Dec 2025

    // PRESS RELEASE

    https://www.centurypharma.com/pregabalin-api-export-opportunities/

    PRESS RELEASE
    04 Dec 2025
    Share Share
    Delhi DCA Warns Chemists on Misuse of Pregabalin, Tapentadol
    Delhi DCA Warns Chemists on Misuse of Pregabalin, Tapentadol

    19 Aug 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=180763&sid=1

    PHARMABIZ
    19 Aug 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.